Boston, MA · 6 min read
Sooner or later, every Boston software company hits the same milestone: a customer's procurement team sends over an MSA that requires errors and omissions coverage before they'll sign. Tech E&O insurance in Massachusetts is, for most venture-backed startups, less a discretionary purchase than a deal requirement — and in a market like Boston's, where your first big customers may be Fortune 500 enterprises, hospitals, or pharma companies, the limits they demand can surprise a seed-stage founder. This guide covers what tech E&O actually protects against, the exposures specific to Cambridge and Kendall Square companies, and how to size limits so coverage never becomes the reason a contract stalls.
Technology errors and omissions insurance (also called professional liability) responds when a client claims your product or service failed and caused them financial harm. Think: your platform goes down during a customer's critical workflow, a software bug corrupts client data, a missed implementation deadline cascades into your customer's losses, or your product simply doesn't perform as the contract promised. General liability covers bodily injury and property damage; it does nothing for pure financial loss from a failed product or service. That's E&O's job. For technology companies, carriers almost always package tech E&O with cyber liability in a single combined form, since a security failure (a breach at your company) and a performance failure (your product letting a customer down) often arise from the same incident. We break down the cyber side — including Massachusetts' 201 CMR 17.00 WISP requirement — in our guide to cyber insurance for Boston and Massachusetts startups. For the full picture of what a standalone or combined policy looks like, see our tech E&O insurance overview.
Boston's tech economy concentrates risk in a few distinctive ways. Enterprise SaaS selling into regulated industries. Boston SaaS companies disproportionately sell into financial services, healthcare, and education — sectors with low tolerance for vendor failure. When your customer is a hospital system or an asset manager, the downstream cost of your outage or data error is large, and their contracts shift that risk to you through indemnification clauses. E&O is how you back those indemnities with actual capital. Life-sciences IT and biotech software. Kendall Square is dense with companies building software for drug discovery, clinical trial management, lab automation, and bioinformatics. If your platform feeds decisions in a research or clinical workflow, an error claim can implicate delayed trials, compromised data integrity, or regulatory submissions built on flawed outputs. Pharma clients know this, which is why their vendor agreements routinely demand E&O limits of $5M or more — figures that startups selling into less regulated markets rarely see. University spinouts from MIT and Harvard. Spinouts carry a particular contractual web: technology licensing agreements with the university, sponsored research agreements, and collaboration deals — many of which include insurance requirements and indemnification obligations from day one. A spinout commercializing licensed IP also faces the question of whether its E&O policy addresses intellectual-property-related claims; many tech E&O forms include some media/IP coverage (typically copyright and trademark, not patent), and the gaps matter. A broker who reads your license agreement alongside your policy can keep those obligations and coverages aligned. Professional services and implementations. Plenty of Boston software companies earn meaningful revenue from implementation, integration, and consulting work. Services engagements generate more E&O claims than pure product subscriptions — scope disputes, missed milestones, and "the system you configured doesn't do what we agreed" allegations are the bread and butter of E&O litigation.